Arcellx (ACLX) EBIT (2021 - 2025)
Arcellx's (ACLX) quarterly EBIT came in at -$63.7 million in Q4 2025, down 19.81% year-on-year from -$79.4 million in Q4 2024, and down 3.09% quarter-over-quarter from -$61.8 million in Q3 2025.
Arcellx (ACLX) EBIT (2021 - 2025) Analysis & Trends
Arcellx's EBIT history runs 5 years deep, the most recent figure standing at -$63.7 million for Q4 2025.
- On a quarterly basis, EBIT fell 19.81% year-over-year to -$63.7 million in Q4 2025; TTM through Dec 2025 was -$253.1 million, a 83.97% decrease from a year earlier, with the FY2025 full-year figure at -$253.1 million, down 83.97% from the prior year.
- EBIT slipped to -$63.7 million in Q4 2025 per ACLX's latest filing, from -$61.8 million in the prior quarter.
- Across five years, EBIT topped out at $15.0 million in Q4 2023 and bottomed at -$93.9 million in Q3 2022.
- The 5-year median for EBIT is -$32.5 million (2022), against an average of -$36.8 million.
- Across the five-year window, EBIT soared 137.49% in 2023 and sank 454.37% in 2024, its largest moves.
- Year by year, EBIT stood at -$20.7 million in 2021, then tumbled by 93.27% to -$40.0 million in 2022, then surged by 137.49% to $15.0 million in 2023, then sank by 454.37% to -$53.2 million in 2024, then fell by 19.81% to -$63.7 million in 2025.
- Per Business Quant, the three latest ACLX EBIT figures stand at -$63.7 million (Q4 2025), -$61.8 million (Q3 2025), and -$58.7 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | -63.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -63.68 Mn |
| Sep 30, 2025 | -61.78 Mn |
| Jun 30, 2025 | -58.73 Mn |
| Mar 31, 2025 | -68.90 Mn |
| Dec 31, 2024 | -53.15 Mn |
| Sep 30, 2024 | -33.62 Mn |
| Jun 30, 2024 | -34.99 Mn |
| Mar 31, 2024 | -15.81 Mn |
| Dec 31, 2023 | 15.00 Mn |
| Sep 30, 2023 | -44.86 Mn |
| Jun 30, 2023 | -29.56 Mn |
| Mar 31, 2023 | -30.46 Mn |
| Dec 31, 2022 | -40.00 Mn |
| Sep 30, 2022 | -93.88 Mn |
| Jun 30, 2022 | -31.29 Mn |
| Mar 31, 2022 | -26.09 Mn |
| Dec 31, 2021 | -20.70 Mn |
| Sep 30, 2021 | -17.11 Mn |
| Jun 30, 2021 | -15.93 Mn |
| Mar 31, 2021 | -11.28 Mn |